entertainment -WSS

entertainment

author：fashion 2025-09-06 04:17:38 - browse：372

Insitro CEO and founder Daphne Koller Neilson Barnard/Getty Images for The New York Times

SAN FRANCISCO — It took only a single, one-hour meeting in a Starbucks to convince venture capitalist Robert Nelsen that he was going to invest in the company being built by machine-learning whiz Daphne Koller. “She’s just an amazing force of nature,” said Nelsen, who invests for ARCH Venture Partners.

Koller’s company, Insitro, in a matter of months raised over $100 million from big-name investors including ARCH, Foresite Capital, Andreessen Horowitz, and the firm that manages Jeff Bezos’ personal VC investments. (Koller refers to Bezos by his first name.) Now, it’s time for the next step. On Tuesday, the giant drug maker Gilead Sciences said it would pay Insitro $15 million — and up to $1 billion more down the line if it meets certain goals — for help in developing drugs to treat a common liver disease. It is the South San Francisco-based company’s first deal with a drug maker, and offers a test of whether artificial intelligence can remake drug development.

The very nature of the financials emphasize the exciting but risky reality: The technology has great promise, but nothing is guaranteed.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： How to save PrEP access — and even expand it

WSS

The Bio Revolution is changing business and society

Hepatitis C has a cure — but many Americans still lack access to it

J&J reports mixed data on next

Novavax promises a turnaround & Lilly roils the obesity market

J&J reports mixed data on next

Ozempic cut risk of death in diabetes patients with chronic kidney disease

entertainment

entertainment

explore

The high cost of giving birth even with insurance

Asahi Kasei to buy Calliditas, picking up kidney disease drug

Walensky prepares to leave CDC — and Congress — behind

Why some fertility treatments produce more boy babies

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Should insurance cover cosmetic surgery?

State Dept. review finds Biden bears some blame for Afghanistan failures

Jerome Adams on the need for new antivirals for Covid

Affirmative action in medical school literally saved lives

As demand for Covid shots wanes, Moderna seeks its next success

knowledge

The Bio Revolution is changing business and society

Bubonic plague hit France in 1720. Officials dithered. Sound familiar?

Bubonic plague hit France in 1720. Officials dithered. Sound familiar?

Hospitals need to get ahead of regulations on climate change

Unmasking the 'centricity' illusion in clinical trials

Louisiana bill approved classifying abortion pills as controlled substances

focus

knowledge

explore

Wikipedia